26/09/2018
Successful Launch of Mérieux Participations 3, The new growth Capital Fund of Mérieux Equity Partners
13/08/2018
Ivantis announces FDA approval for its innovative Hydrus Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)
13/08/2018
Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights
28/06/2018
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offering in the U.S.
25/06/2018
XERIS PHARMACEUTICALS announces positive phase 3 clinical trial data on its investigational ready-to-use Glucagon rescue pen
20/06/2018